Skip to main
CRDL
CRDL logo

Cardiol Therapeutics (CRDL) Market Capitalization Overview

Market Cap: $120.67M as of Jun 13, 2025

$120.67M
Past Month+$26.48M (28.10%)
As of Jun 13, 2025, Cardiol Therapeutics (CRDL) has a market capitalization of $120.67M. Over the past 30 days, its market cap has increased by 10.74%, while in the last 12 months, it has increased by 15.52%.

Market capitalization represents the total value of Cardiol Therapeutics as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

Cardiol Therapeutics (CRDL) Market Cap Formula = Stock Price * Shares Outstanding

The market cap of Cardiol Therapeutics (CRDL) helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Cardiol Therapeutics (CRDL) Market Cap History

DateMarket CapChange
Jun 2, 2025$102.49M+10.74%
May 1, 2025$92.55M+22.26%
Apr 1, 2025$75.70M-14.90%
Mar 3, 2025$88.95M-18.05%
Feb 3, 2025$108.54M-2.92%
Jan 2, 2025$111.80M-12.74%

Cardiol Therapeutics (CRDL) End of Year Market Cap History

DateMarket CapChange
2025$120.67M+15.52%
2024$104.46M+90.25%
2023$54.91M+71.75%
2022$31.97M-33.24%
2021$47.89M-15.14%
2020$56.43M

FAQs About Cardiol Therapeutics (CRDL) Market Cap

As of Jun 13, 2025, the market capitalization of Cardiol Therapeutics (CRDL) is $120.67M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Cardiol Therapeutics’s market capitalization has increased by 28.10%, changing from $94.20M to $120.67M as of Jun 13, 2025.

In the last 3 months, Cardiol Therapeutics’s market capitalization has increased by —, changing from – to – as of –.

In the year 2024, Cardiol Therapeutics’s market capitalization increased from $54.91M in January to $104.46M in December, reflecting a 90.25% change.

In the past five years, Cardiol Therapeutics (CRDL) has had a compound annual growth rate (CAGR) of 13.11% in market capitalization. This means its market cap has grown at an average rate of 13.11% per year.

Cardiol Therapeutics (CRDL)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.